WallStreetZenWallStreetZen

NASDAQ: CKPT
Checkpoint Therapeutics Inc Stock Ownership - Who owns Checkpoint Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Checkpoint Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
James F. Oliviero IiiCEO President and Director2025-04-0215,090$4.04
$60.96kSell
William Garrett GrayChief Financial Officer2025-04-0112,322$4.05
$49.90kSell
James F. Oliviero IiiCEO President and Director2025-02-1010,331$3.15
$32.54kSell
James F. Oliviero IiiCEO President and Director2025-02-079,233$3.41
$31.48kSell
William Garrett GrayChief Financial Officer2025-02-0674,110$3.67
$271.98kSell
James F. Oliviero IiiCEO President and Director2024-12-19220,230$3.38
$744.38kSell
James F. Oliviero IiiCEO President and Director2024-12-18602,167$3.87
$2.33MSell
William Garrett GrayChief Financial Officer2024-12-18268,432$4.01
$1.08MSell
William Garrett GrayChief Financial Officer2024-06-2613,038$2.06
$26.86kSell
James F. Oliviero IiiCEO President and Director2024-06-2624,610$2.05
$50.45kSell

1 of 1

CKPT insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CKPT insiders and whales buy or sell their stock.

CKPT Shareholders

What type of owners hold Checkpoint Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Fortress Biotech Inc7.43%6,222,249$25.57MInsider
Armistice Capital LLC5.33%4,460,545$18.33MInstitution
James F. Oliviero Iii4.49%3,759,929$15.45MInsider
Vanguard Group Inc2.27%1,897,433$7.80MInstitution
William Garrett Gray1.73%1,446,322$5.94MInsider
Susquehanna International Group LLP0.57%478,805$1.97MInstitution
Geode Capital Management LLC0.53%445,111$1.83MInstitution
Wealth Enhancement Advisory Services LLC0.51%425,000$1.75MInstitution
Kestra Advisory Services LLC0.39%329,281$1.35MInstitution
Morgan Stanley0.34%286,991$1.18MInstitution

1 of 3

CKPT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CKPT13.20%14.60%Net SellingNet Selling
OLMA74.06%25.94%Net Selling
ARCT87.85%12.15%Net Selling
AUTL63.24%0.00%
RIGL32.39%67.61%Net SellingNet Selling
View Top Biotech Stocks

Checkpoint Therapeutics Stock Ownership FAQ

Who owns Checkpoint Therapeutics?

Checkpoint Therapeutics (NASDAQ: CKPT) is owned by 13.20% institutional shareholders, 14.60% Checkpoint Therapeutics insiders, and 72.21% retail investors. Fortress Biotech Inc is the largest individual Checkpoint Therapeutics shareholder, owning 6.22M shares representing 7.43% of the company. Fortress Biotech Inc's Checkpoint Therapeutics shares are currently valued at $25.51M.

If you're new to stock investing, here's how to buy Checkpoint Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.